...
首页> 外文期刊>Oncology reports >Correlation between pathological data and the RNA expression of p53 or p53-targeted genes in primary invasive ductal breast carcinomas: a preliminary study.
【24h】

Correlation between pathological data and the RNA expression of p53 or p53-targeted genes in primary invasive ductal breast carcinomas: a preliminary study.

机译:病理数据与原发性浸润性导管癌中p53或p53靶向基因的RNA表达之间的相关性:一项初步研究。

获取原文
获取原文并翻译 | 示例
           

摘要

The protein expression of the growth suppressive p53 transcription factor and its inhibitor human double minute 2 (Hdm2) is altered in ductal breast carcinomas (DBC). However, the assessment of p53 and/or Hdm2 protein levels in DBC tissues was found to have a questionable prognostic significance. We evaluated the RNA expression of p53, hdm2, and the p53-targeted p21waf-1 and thrombospondin (tsp)-1 by primary DBC tissues, then correlated the RNA levels with patient clinicopathological data. The mean RNA expression level of p53 and that of hdm2 were elevated in large-sized, poorly differentiated, node-positive DBC, while a high p21waf-1 or tsp-1 mean expression level comprised small-sized, low-grade, node-negative tumors. Further analyses found that the correlation between the RNA expression of p53 and that of its targeted genes was reduced as tumor aggressiveness increased. However, for all the examined genes, association of the intensity of RNA expression with the pathological data was not statistically significant (p>0.05). Altogether, our preliminary RNA data confirm the results from previous protein studies, indicating that despite p53 expression and activity show a trend to vary in association with DBC clinical features, neither p53 nor its transcriptional targets can accurately monitor the behaviour of invasive DBC.
机译:生长抑制性p53转录因子及其抑制剂人doubleminute 2(Hdm2)的蛋白表达在乳腺导管癌(DBC)中发生改变。但是,发现DBC组织中p53和/或Hdm2蛋白水平的评估具有可疑的预后意义。我们评估了原发性DBC组织的p53,hdm2和p53靶向的p21waf-1和血小板反应蛋白(tsp)-1的RNA表达,然后将RNA水平与患者的临床病理数据相关联。在大型,低分化,淋巴结阳性的DBC中,p53和hdm2的平均RNA表达水平升高,而高p21waf-1或tsp-1的平均表达水平则包括小,低级,结阴性肿瘤。进一步的分析发现,随着肿瘤侵袭性的增加,p53的RNA表达与其靶向基因的RNA表达之间的相关性降低。但是,对于所有检查的基因,RNA表达强度与病理数据之间的相关性在统计学上均无统计学意义(p> 0.05)。总而言之,我们的初步RNA数据证实了先前蛋白质研究的结果,表明尽管p53的表达和活性显示出与DBC临床特征相关的变化趋势,但p53或其转录靶标均无法准确监测侵袭性DBC的行为。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号